RMark Bio

RMark Bio, founded in 2015, operated as a business intelligence software developer focused on the life sciences sector. The company was established by co-founders Jason M. Smith, who served as CEO, and Lev Becker, Ph.D., who acted as the Chief Scientist. Their core mission was to simplify the adoption and use of artificial intelligence for pharmaceutical companies to accelerate scientific discovery and collaboration.

The firm's primary offering was a sophisticated analytics platform designed to assist pharmaceutical companies in identifying suitable academic partners, thereby optimizing engagement strategies throughout a product's lifecycle. This was achieved by analyzing global healthcare data in conjunction with a client's internal clinical research data. The platform, known as Fabric™, was an end-to-end AI solution that automated the aggregation and preparation of data for machine learning, using neural networks to surface scientific insights. One of its key applications, Cue™, functioned as an AI assistant to help companies find and manage relationships with relevant healthcare providers. RMark Bio's business model targeted top-tier pharmaceutical companies, providing services to many of the top 20 globally.

Throughout its operation, the company achieved several milestones. It secured multiple rounds of seed funding, totaling over $6 million, with a significant round of $2.77 million in October 2020. Strategic partnerships were a key element of its growth, including collaborations with Microsoft, Google, and nVidia. A notable partnership was formed with the healthcare incubator MATTER, which led to the joint launch of 'Origin,' an intelligent matchmaking engine connecting startups with large healthcare organizations. In March 2020, RMark Bio, alongside West Monroe Partners, established the first Medical Affairs AI Center of Excellence. The company's journey as an independent entity concluded on April 27, 2021, when it was acquired by Within3, a move intended to leverage Within3's market access and accelerate the deployment of RMark's technology.

Keywords: life sciences AI, pharmaceutical analytics, business intelligence software, scientific discovery, partnership optimization, academic collaboration, data analytics platform, medical affairs, healthcare data, AI matchmaking